Ahmedabad-based contract research and manufacturing services (CRAMS) company Dishman Pharmaceuticals and Chemicals has posted a net profit of Rs 10.61 crore during the second quarter of the current fiscal as against a loss of Rs 35.92 crore in the corresponding period previous fiscal. The company's net sales grew by 6 per cent to Rs 113.85 crore during Q2FY13, compared to Rs 107.31 crore in the year before period.
On a consolidated basis, Dishman posted net sales of Rs 289.26 crore, up 7.6 per cent compared to Rs 268.84 crore in the corresponding period last financial year. Consolidated net profit for the quarter stood at Rs 26.56 crore as against a loss of Rs 63.61 crore.
For the first half of the year, the company posted a consolidated turnover of Rs 604.54 crore up 19.46 per cent on a year-on-year basis. Profit after tax for the first half stood at Rs 65.31 crore, the company said in a statement.
During the quarter Carbogen Amcis posted a turnover of Rs 111.40 crore during the quarter under review, and for the first half of the year this Swiss subsidiary of Dishman posted a turnover of Rs 244.37 crore. Dishman Netherlands posted a turnover of Rs 52.17 crore during the second quarter of the fiscal, from Rs 33.62 crore in the year before period.